O'Brien Medical, founded by Todd O’Brien in 1999, focuses on developing innovative medical devices for the neurodiagnostic market. Their flagship product, the ETF128, is a novel vibratory sensation testing instrument designed to aid in diabetes management by preventing diabetic foot complications. After a five-year development and testing process, the ETF128 is now commercially available and positioned as the core offering in the growing neurodiagnostic sector.
Despite its innovative contributions, O'Brien Medical is currently seeking an acquirer and has paused production and order-taking activities. The company's impact includes advancing neurodiagnostic tools and improving diabetic care through their unique testing instruments. The ETF128 stands out as a significant achievement in the medical device industry, reflecting the company's commitment to enhancing patient outcomes through advanced technology.